Although no conclusive data is present about the function of metformin in both cancer therapy and prevention either in diabetic or in nondiabetic populations, the possible effects are observed indirectly on systemic levels of glucose or insulin, or directly on tumor cell growth via inhibition of cell proliferation and survival via induction of cell death [10,26–30]. Here, INS is linked to neoplasm.